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1. Introduction 
Matrix-free mitochondrial membrane preparations 
of baker’s yeast are able to carry out a Mg”dependent 
synthesis of 3-all-frans-hexaprenyl4_hydroxy- 
benzoate, acompound that has been proposed as the 
first intermediate on the pathway leading from 
4-hydroxybenzoate o ubiquinone@Q-6) in yeast 
[ 1 ] , from 4-hydroxybenzoate, isopentenyl pyrophos- 
phate (IPP) and ~,ydimethylallyl pyrophosphate 
(7,-y-DMAPP) [Casey, J. and Threlfall, D. R, unpub- 
lished] .The membrane preparations were, however, 
unable to synthesise ither any other compounds that 
might be intermediates on the pathway leading to 
Q-6 or Q-6. Indirect support for the involvem&t of 
3-hexaprenyl4-hydroxybenzoate in the biosynthesis 
of Q-6 has been provided by the isolation from a 
Q-6-deficient mutant of bakers yeast of 3,4-dihydroxy- 
S-hexaprenylbenzoate [2], a compound that could 
be the second intermediate on a pathway having 
3-hexaprenyl4hydroxybenzoate s the first inter- 
mediate. It can of course also be argued that the iso- 
lation of this compound provides indirect support for 
a pathway in which 3,4dihydroxybenzoate is the 
first intermediate formed from 4-hydroxybenzoate; 
c.f. the recent report that 3,4dihydroxybenzoate can 
be formed from 4-hydroxybenzoate in rat liver slices 
and that 3,4-dihydroxy-S-polyprenylbenzoates can 
be synthesised from 3,4dihydroxybenzoate and poly- 
prenylpyrophosphates in rat liver mitochondria [3] . 
In the present paper we report on the ability of 
mitochondria isolated from yeast protoplasts to syn- 
thesise 6-methoxy-2-hexaprenylphenol, 5demethoxy- 
ubiquinoned and ubiquinone-6 from either 
Elsevier/North-Holland Biomedical Press 
4-hydroxybenzoate and IPP or 3-hexaprenyl4- 
hydroxybenzoate. 
2. Materials and methods 
2.1. Materials 
4-Hydroxy [U-‘“Cl benzoate (400 pCi/pmol) was 
prepared from L-[U-‘4C] tyrosine (5 13 E.cCi/mol) by 
an enzymatic procedure [Casey, J., unpublished] . 
LisIPP and (NH4)3-~;y-DMAPP, were prepared from 
the appropriate alcohols [4]. All other reagents were 
of the best grades available from commercial sources. 
2.2. Isolation of mitochondria 
Saccharomyces carlsbergensis NCYC 74 was grown 
aerobically at 30°C on 2% (v/v) ethanol, 0.5% (w/v) 
mycological peptone and 0.3% (w/v) yeast extract in 
distilled water. The cells were harvested in midexpo- 
nential phase by centrifugation and their protoplasts 
prepared by a routine procedure [S] . After resuspen- 
sion in 0.2% (w/v) bovine serum albumin/O.6 M
mannitol/0.05 Mphosphate buffer, pH 7.4, the proto- 
plasts were ruptured by one passage through a pres- 
sure cell (3000 lb/in?) and the resultant homogenate 
centrifuged at 1500 X g for 10 min followed by 
8000 X g for 10 min. The 8000 X g mitochondrial 
pellet was washed twice with bovine serum albumin/ 
mannitol/phosphate buffer before final resuspension 
in a small volume of bovine serum albumin/mannitol/ 
phosphate buffer. 
2.3. Radiochemical assay of biosynthetic activity 
The standard assay mixture was prepared by 
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adding 0.25 ml of mitochondrial suspension (5-8 mg 
protein) to 1.15 ml 0.6 M sorbitol/0.05 M phosphate 
buffer, pH 7.4, which contained 1 .l X 10’ dpm 
(125 pmol) 4-hydroxy [U-‘“Cl benzoate (400 pCi/ 
pmol), 0.5 Mm01 LisIPP, 10 pm01 MgC12, 0.27 pmol 
S-adenosylmethionine (SAM), 0.375 I.tmol ATP, 
0.27 pmol NADPH and 5.4 pmol succinate. The mix- 
ture was incubated in a 25 ml conical flask for the 
appropriate period of time at 30°C with gentle agita- 
tion. 
At the end of the inocubation period the reaction 
was stopped by the rapid addition of 5 vol chloro- 
form-methanol (1:2, v/v) and the chloroform- 
soluble lipids (this extract contained 3-hexaprenyl- 
4-hydroxybenzoate, 6-methoxy-2-hexaprenylphenol, 
5-demethoxyQ-6 and Q-6) extracted and assayed for 
radioactivity [1 ] . In some experiments he aq. 
methanol fraction was adjusted to pH 2 and extracted 
with diethyl ether (3X) to recover unused 4-hydroxy 
[U-‘4C]benzoate and any unprenylated [U-'"Cl - 
benzoates produced in the course of the incubation. 
2.4. Identification of “C-products 
The chloroform-soluble lipids were subjected to 
thin-layer chromatography (TLC) on silica gel G 
developed with cyclohexane-diethyl ether (9:2, v/v) 
(3.hexaprenyl4-hydroxybenzoate, RF 0.05; 
5-demethoxyQH,-6, RF 0.15; 5-demethoxyQ-6, RF
0.18; QH,-6, RF 0.24:Q-6, RF 0.27 and 6-methoxy- 
2-hexaprenylphenol, RF 0.55). The r4C-labelled 
compounds were located with a Panax TL Chromato- 
gram Scanner, eluted from the gel, assayed for radio- 
activity content and their identities confirmed by 
rechromatography in appropriate TLC systems ((3-hexa- 
prenyl4-hydroxybenzoate; silica gel H developed 
with acetone-light petroleum (b.p.40-6O”C) (3:7, 
v/v) (RF 0.33) and then paraffin-impregnated silica 
gel G developed with aq. 75%(v/v) acetone (RF 0.44): 
Q-6, QHz-6, 5-demethoxyQHs-6,5-demethoxyQ-6 and 
6-methoxy-2-hexaprenylphenol: paraffin-impregnated 
silica gel G developed with either aq. 90% (v/v) acetone 
or aq. 95% (v/v) acetone (see [6] forRF values)). As 
final confirmation of their identities, the 5-demethoxy- 
[14C]Q-6 and [ 14C]Q-6 were reduced to the corre- 
sponding quinols with Zn/HCl and subjected to 
adsorptive and reversed-phase TLC (see above for RF 
values). 
The diethyl ether extract of the acidified aq. 
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methanol fraction was examined for the presence of 
[ 14C] benzoates by TLC on silica gel H developed 
with benzene-acetic acid (4: 1, v/v) 3,4dihydroxy- 
benzoate, RF 0.17; 4-hydroxybenzoate, RF 0.42; 
3-methoxy4-hydroxybenzoate, RF 0.57). 
3. Results 
3 .l . Synthesis of 5demethoxyQ-6 and Q-6 by yeast 
mitochondria 
Mitochondria from yeast protoplasts were tested 
for their ability to form 14C-labelled chloroform- and 
aq. [ “C]methanol-soluble compounds when incubated 
with 4-hydroxy[U-14C]benzoate, IPP, y;y-DMAPP, 
Mg2’ and some of the supplements u ed in the success- 
ful demonstration of Q-9 biosynthesis from 4-hydroxy- 
benzoate in rat liver mitochondria [7] . The results 
showed that fully supplemented mitochondria 
incorporated 14C radioactivity into four chloroform- 
soluble compounds which had TLC properties iden- 
tical to those of 3-hexaprenyl4-hydroxybenzoate, 
6-methoxy-2-hexaprenylphenol, 5demethoxyQ-6 
and Q-6 (table 1; expt. 1). Mitochondria incubated 
with 4-hydroxy-[U-‘4C]benzoate, IPP, 7,-r-DMAPP 
and Mg2’ incorporated radioactivity into 3-hexa- 
prenyl4-hydroxybenzoate and, to a very limited 
extent, 5-demethoxyQ-6, whereas mitochondria 
incubated with 4-hydroxy [U-‘4C] benzoate and the 
supplements u ed to demonstrate Q-9 biosynthesis 
in rat liver mitochondria formed no 14C-labelled 
chloroform-soluble compounds (table 1; expt. 1). On 
examination of the diethyl ether extracts from the 
aq. methanol washings, it was found that the only 
radioactive compound they contained was the 
14C-labelled substrate. In each incubation the total 
amount of administered radioactivity was accounted 
for by the 14C activity recovered in the chloroforrn- 
soluble compounds (after correction for loss of 
14C02) and the unreacted 14C-labelled substrate. 
Subsequent experiments demonstrated that the 
omission of -y,7-DMAPP, CoASH and methionine 
from the incubation mixture had no effect on the 
types and amounts of i4C-labelled compounds 
produced, and that to obtain good rates of synthesis 
of 5demethoxyQ-6 and Q-6 it is essential to have 
undamaged mitochondria (table 1; expt. 2). 
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Table 1 
Incorporation of radioactivity from 4-hydroxy[U-“Clbenzoate into Qd and related compounds in undamaged 
(expt. 1) and damaged (expt. 2) mitochondria 
“C Activity (lo-” dpm) in CHCl,-soluble compoundsa 
Incubation conditions 3-Hexaprenyl- 6-Methoxy- 5Demethoxy- 
4-hydroxybenzoate 2-hexaprenylphenol Q-6 Q-6 
Expt. 1 
No supplement 0 0 0 0 
Complete 41.4 6.3 35.1 11.1 
Complete-IPP and r,y-DMAPP 0 0, 0 0 
Mg’+, IPP and -y,~-DMAPP 75.6 0 1.8 0 
Expt. 2 
Standard assay 21.4 2.0 32.5 6.5 
- Sorbitol 57.8 0 7.6 0 
- Sorbitol + ultrasound 62.7 0 3.4 0 
aAfter allowing for the loss of “CO, in the formation of 6-methoxy-2-hexaprenylphenol, 5demethoxyQ-6 and 
Q-6, the administered “C activity was entirely accounted for by the ‘%Y activity in the CHCl, -soluble compounds + 
unreacted “C-labelled substrate 
Expt. 1. Mitochondria (6 mg protein) were incubated with 4-hydroxy[U-“Clbenzoate and the various combinations 
of supplements hown in the table for 2 h. The complete system consisted of the standard assay mixture supplement- 
ed with 1.0 pmol T,-/-DMAPP, 0.135 nmol CoASH and 1.35 pmol L-methionine. 
Expt. 2. Mitochondria (7.25 mg protein) were (i) incubated under standard assay conditions, (ii) incubated in a 
sorbitol-deficient incubation mixture and (iii) suspended in a sorbitoldeficient incubation mixture and exposed to 
ultrasound for 3 s prior to the incubation. The mixtures were all incubated for 2 h 
3.2. Attempt to detect other intermediates 
Attempts were made to cause the accumulation of 
other possible intermediates on the pathway to Q-6 
by incubating the standard assay mixture under 
anaerobic onditions or by the omission of SAM from 
the standard assay mixture. Under both sets of con- 
ditions the only 14C-labelled compound produced was 
3-hexaprenyl4-hydroxybenzoate. It was also found 
that the additions of a CoA ester trapping reagent 
(hydroxylamine) to the standard assay mixture had 
no effect on the types and amounts of products. 
3.3. Synthesis of 6-methoxy-2-hexaprenylphenol, 
5-demethoxyQ-6 and Q-4 from 3-hexaprenyl- 
#-hydroxybenzoate 
Mitochondria that had been allowed to accumu- 
late 3-hexaprenyl [U-‘*Cl benzoate were incubated 
with the cofactors needed for the conversion of 
this 14C-labelled compound into Q-6. The results 
showed that 3-hexaprenyl4hydroxybenzoate can 
act as a precursor of 6-methoxy-2hexaprenylphenoL 
5-demethoxyQ-6 and Q-6 (fig.1). The relatively poor 
incorporation of radioactivity into Q-6 was attributed 
to damage of the mitochondria in the washing proce- 
dure which followed the preincubation step. 
4. Discussion 
The results of this study show that undamaged 
yeast mitochondria re able to carry out the synthesis 
of 3-hexaprenyl-4-hydroxybenzoate, 6-methoxy-2- 
hexaprenylphenol, 5-demethoxyQ-6 and Q-6 starting 
from 4-hydroxybenzoate and IPP (table 1). The 
synthesis of the first compound, as in the synthesis of 
2-nonaprenyl4-hydroxybenzoate in rat liver mito- 
chondria [8] , is Mg*‘-dependent (Casey, J., unpub- 
lished) and requires only 4-hydroxybenzoate and 
IPP, whereas the synthesis of the other compounds 
needs the addition of supplements similar to those 
required for the formation of Q-9 from 4-hydroxy- 
benzoate in ‘programmed’ rat liver mitochondria 
(mitochondria isolated from homogenates that have 
been preincubated with MVA to increase the size of 
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’ (TEP i STEP 2 ’ I 
Time(h) 
Fig. 1. Synthesis of 6-methoxy-2-hexaprenylphenol ( -o), 
5demethoxyQ-6 (~---a) and Q6 (o--o) from 4-hexa- 
prenyl+hydroxybenzoate (e----e). 
Step 1. Mitochondria (21 mg protein) were incubated with 
3.3 X 10’ dpm (375 pmol) 4-hydroxy[U-“CJbenzoate, 
1 rmol Li,IPP, 10 Hmol MgCl,, 2 mg bovine serum albumin 
in 2.7 ml 0.6 M mannitol/0.05 M phosphate buffer, pH 7.4, 
for 1 h. At the end of this time the volume of the incubation 
mixture was adjusted to 15 ml by the addition of 0.2% (w/v) 
bovine serum albumin in ice-cold mannitol/phosphate buffer 
and the diluted suspension centifruged at 10 000 X g for 
10 min. The supernatant (this contained all the unreacted 
4-hydroxy [ W’C] benzoate) was discarded and the mitochon- 
drial pellet resuspended in 1.5 ml of bovine serum albumin/ 
mannitol/phosphate buffer. 
Step 2. One-third of the mitochondrial suspension was 
analysed for the presence of “C-1abelled CHCl, -soluble 
compounds. The remaining two-thirds was divided into two 
equal parts which were then incubated with the standard 
assay mixture - IPP for 60 min and 110 min, respectively, 
and then analysed. 
the mitochondrial pool of polyprenyl-pyrophos- 
phates) [7] . 
No evidence was obtained for the formation of: 
(i) [14C] Benzoates of the type recently implicated 
in the biosynthesis of Q-9 in rat liver mitochondria 
131. 
(ii) Hexaprenyl analogues of benzoyl CoA compounds 
of the type once considered as intermediates in 
the biosynthesis of Q-9 in rat tissues [7] e.g., 
3-hexaprenyWhydroxybenzoy1 CoA. 
(iii) Other prenylated compounds such as the 3,4- 
dihydroxy-Shexaprenylbenzoate isolated from a 
Q-deficient yeast mutant [2]. 
Indirect evidence for the involvement of 3-hexa- 
prenyl4hydroxybenzoate in the biosynthesis of 
6-methoxy-2-hexaprenylphenol, 5demethoxyQ-6 
and Q-6 was provided by the findings that in those 
incubations in which as a result of the omission of 
cofactors other than IPP and Mg2’, anaerobis or 
damage to mitochondria the incorporation of radioa 
activity into the last three compounds was reduced 
there was always a concomittant increase in the 
amount of radioactivity incorporated into 3-hexa- 
prenyl4hydroxybenzoate (table 1). Direct support 
for a precursor-product relationship between 
3-hexaprenyl4hydroxybenzoate and 6-mothoxy-2- 
hexaprenylphenol, S-demethoxyQ-6 and Q-6 was 
provided by the experiment described in the fig.1. 
This demonstration is the first to provide good 
evidence in support of the proposal that 3-poly- 
prenyl+hydroxybenzoates can act as precursors of 
Qs in eukaryotic cells [ 1,2,8] . In a previous study it 
was claimed that a pulse-chase xperiment with 
4-hydroxy-[U-14C]benzoate had established a pre- 
cursor product relationship between 3nonaprenyl- 
4-hydroxybenzoate and Q-9 in rat liver mince [8]. 
On critical examination of the published data, how- 
ever, it is apparent that the rate of disappearance of 
i4C-labelled 3nonaprenyWhydroxybenzoate was 
far greater than the rate of appearance of 14C Q-9, 
i.e., a result that could equally well indicate that 
there is no precursor-product relationship between 
these two compounds. If it is accepted that 3,4- 
dihydroxy-5-hexaprenylbenzoate is an intermediate 
on the pathway to Q-6 [2], then the results of the 
present study coupled with the previous demonstra- 
tion that 5-demethoxyQ-6 is a precursor of Q-6 in 
yeast [9] provide further support for the pathway 
that has been put forward for eukaryotic cells [2] : 
4-hydroxybenzoate + 3-polyprenyl4-hydroxy- 
benzoate -+ 3,4-dihydroxy-5-polyprenylbenzoate + 
6-methoxy-2-polyprenylphenol-+ 5-demethoxyQ-6 + 
Q-6. 
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